Ina-Respond: Clinical Trials

1 trial sponsored by Ina-Respond, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Ina-Respond: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients
allogeneic mesenchymal stem cell, Placebo - Covid19, Corona Virus Infection
Phase 1CompletedIna-Respond92020-11-142021-01-27

Conditions studied

COVID-19 (1)  ·  Communicable Diseases (1)  ·  Coronavirus Infections (1)

Countries

Indonesia (1)

Top investigators

Dr. Muhammad Karyana, MPH (1)

Results publications

PMID 35365239